Medical Imaging Reagents Market by Class - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4403094
  • Report
  • Region: Global
  • 160 pages
  • Allied Analytics LLP
1 of 3
Medical imaging reagents are chemicals used in imaging and detection technologies to visualize organs or structures. These reagents enable physicians to diagnose and detect diseases, thus playing a vital role in the healthcare and medical industry. The modern approach involves using these reagents in animal research before their reaction can be evaluated on humans. These reagents have addressed the increasing need for better therapeutics as they assist in detecting changes at the molecular level with the aid of X-ray and ultrasound. The global medical imaging reagents market was valued at $10,772 million in 2016, and is estimated to reach $18,587 million by 2023, registering a CAGR of 8.0% from 2017 to 2023.

The global medical imaging reagents market is driven by rise in cases of chronic diseases such as cancer and cardiovascular diseases, increase in technological advancements, and high unmet medical and diagnostic imaging procedure needs. In addition, rise in geriatric population, increase in expenditure on healthcare, and growth in demand for effective procedures and safe medication are expected to fuel the market growth. However, lack of reagent suppliers and strict government regulations restrict this growth in developing regions.

The global medical imaging reagents market is segmented based on class, technology, application, and geography. Based on class, it is divided into contrast reagents, optical reagents, and nuclear reagents. The technology segment includes nanoparticles, fluorescent dyes & probes, radiopharmaceuticals, fluorescent proteins, and quantum dots. Based on application, the market is categorized into diagnostics, drug discovery & development, and R&D. Based on geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report offers a detailed quantitative analysis of the current market trends of the global medical imaging reagents market from 2016 to 2023 to identify the prevailing opportunities.
The market estimations are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive market scenario.

KEY PLAYERS PROFILED

Bracco Imaging SpA
Bayer Healthcare AG
Lantheus Medical Imaging, Inc.
GE Healthcare
Siemens Healthcare
Covalon Technologies Ltd.
Thermo Fisher Scientific, Inc.
Merck
Philips Healthcare
Shimadzu Corporation

KEY MARKET SEGMENTS

By Class

Contrast Reagents
Optical Reagents
Nuclear Reagents

By Technology

Nanoparticles
Fluorescent Dyes & Probes
Radiopharmaceuticals
Fluorescent Proteins
Quantum Dots

By Application

Diagnostics
Drug Discovery & Development
R&D

BY GEOGRAPHY

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
Rest of Asia-Pacific
LAMEA
Brazil
Republic of South Africa
Saudi Arabia
Rest of LAMEA

The other players of the dialysis market include (companies not profiled in the report):

Guerbet Group
Daiichi Sankyo
nanoPET Pharma GmbH
Subhra Pharma Private Limited
CMC Contrast AB
READ MORE
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Growth in number of geriatric population
3.5.1.2. Increase in prevalence of chronic diseases
3.5.1.3. Rise in demand for diagnostic imaging procedures

3.5.2. Restraints

3.5.2.1. Shortage of supplies of imaging reagents
3.5.2.2. Stringent regulatory approvals
3.5.2.3. Reluctance in adopting nuclear reagents

3.5.3. Opportunities

3.5.3.1. Technological Advancements Leading
3.5.3.2. Development of personalized therapy
3.5.3.3. Untapped Markets in Developing Economies

CHAPTER 4 MEDICAL IMAGING REAGENTS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CONTRAST REAGENTS

4.2.1. Market size and forecast

4.3. OPTICAL REAGENTS

4.3.1. Market size and forecast

4.4. NUCLEAR REAGENTS

4.4.1. Market size and forecast

CHAPTER 5 MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NANOPARTICLES

5.2.1. Market size and forecast

5.3. FLUORESCENT DYES & PROBES

5.3.1. Market size and forecast

5.4. RADIOPHARMACEUTICALS

5.4.1. Market size and forecast

5.5. FLUORESCENT PROTEINS

5.5.1. Market size and forecast

5.6. QUANTUM DOTS

5.6.1. Market size and forecast

CHAPTER 6 MEDICAL IMAGING REAGENTS MARKET, BY APPLICATIONS

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. DIAGNOSTICS

6.2.1. Market size and forecast

6.3. DRUG DISCOVERY & DEVELOPMENT

6.3.1. Market size and forecast

6.4. R&D

6.4.1. Market size and forecast

CHAPTER 7 MEDICAL IMAGING REAGENTS MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Mexico market size and forecast
7.2.3.3. Canada market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. UK market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. Germany market size and forecast
7.3.3.4. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. India market size and forecast
7.4.3.2. Japan market size and forecast
7.4.3.3. China market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. BRACCO IMAGING SPA

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments

8.2. BAYER HEALTHCARE AG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments

8.3. LANTHEUS MEDICAL IMAGING, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments

8.4. GE HEALTHCARE

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments

8.5. SIEMENS HEALTHCARE

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments

8.6. MALLINCKRODT PHARMACEUTICALS

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments

8.7. THERMO FISHER SCIENTIFIC, INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments

8.8. MERCK

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments

8.9. BECTON DICKINSON & COMPANY

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments

8.10. CARDINAL HEALTH, INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll